Logo image
Mucosal immune cell priming by intranasally delivered Haemophilus haemolyticus is associated with heterologous protection against influenza and nontypeable Haemophilus influenzae
Journal article   Open access   Peer reviewed

Mucosal immune cell priming by intranasally delivered Haemophilus haemolyticus is associated with heterologous protection against influenza and nontypeable Haemophilus influenzae

Jack S Pepper, Caitlyn M Granland, Sharon L Clark, Ruth B Thornton, Josephine Bayliss, M Z Edison Foo, Wesley Billingham, Naomi Scott, Alma Fulurija, Deborah H Strickland, …
Frontiers in immunology, Vol.17, 1855464
2026
PMID: 42548815
pdf
Published5.20 MBDownloadView
Open Access CC BY V4.0

Abstract

Administration, Intranasal Animals Female Haemophilus Infections - immunology Haemophilus Infections - microbiology Haemophilus Infections - prevention & control Haemophilus influenzae - immunology Haemophilus Vaccines - administration & dosage Haemophilus Vaccines - immunology Humans Immunity, Mucosal Influenza A virus - immunology Mice Orthomyxoviridae Infections - immunology Orthomyxoviridae Infections - prevention & control
Introduction: Intranasal vaccines offer a needle-free strategy to enhance immunity to respiratory infections. We investigated the mechanism of action of a novel intranasal vaccine using the human respiratory commensal Haemophilus haemolyticus (Hh), previously shown to protect against nontypeable Haemophilus influenzae (NTHi) otitis media and accelerate clearance of influenza A virus (IAV). Methods: Mucosal and systemic cellular immune responses were assessed 2–144 hours after intranasal Hh treatment in mice, compared with placebo or the Toll-Like Receptor (TLR)2–6 agonist Pam2CSK4 using spectral flow cytometry. The impact of treatment on subsequent IAV and NTHi challenge was also evaluated. Results: Hh induced a distinct, tissue-specific immune signature with rapid recruitment of neutrophils and inflammatory monocytes to the lungs, peaking at 6 hours, earlier than Pam2CSK4. Hh also generated higher proportions of nasal CD103+CD4+ T cells within 48 hours, which further expanded following sequential IAV and NTHi infection. Discussion: These findings demonstrate that Hh primes mucosal immune responses to promote heterologous protection.

Details

Metrics

1 Record Views
Logo image